Michael Cullen
Impact in
- Oncology top 5%
- Neutropenia and Cancer Infections
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in ⓘ
- Oncology 22
- Lung Cancer Research Studies 12
- Neutropenia and Cancer Infections 6
-
- Lung Cancer Treatments and Mutations 14
- Co-authors
- Michael A. Russell (1 shared paper)Lucinda Billingham (2 shared papers)Neil Steven (2 shared papers)Claire Gaunt (2 shared papers)Robert Huddart (4 shared papers)Peter Simmonds (1 shared paper)Simon Gollins (1 shared paper)Mark Hastings (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Lung Cancer (5 papers)Journal of Thoracic Oncology (4 papers)Cancer Chemotherapy and Pharmacology (2 papers)Expert Review of Anticancer Therapy (2 papers)
- Partner nations
- United KingdomUnited StatesCzechia
In The Last Decade
Michael Cullen
42 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 80
- Oncology 964
- Clinical Biochemistry 186
- Pulmonary and Respiratory Medicine 487
- Pathology and Forensic Medicine 210
- Emergency Medicine 95
Countries citing papers authored by Michael Cullen
This map shows the geographic impact of Michael Cullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Cullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Cullen more than expected).
Fields of papers citing papers by Michael Cullen
This network shows the impact of papers produced by Michael Cullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Cullen. The network helps show where Michael Cullen may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Cullen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 275 | |
| 2 | 2008 | 176 | |
| 3 | 2006 | 129 | |
| 4 | 1992 | 107 | |
| 5 | 2005 | 95 | |
| 6 | 2017 | 88 | |
| 7 | 1999 | 52 | |
| 8 | 2010 | 50 | |
| 9 | 1986 | 49 | |
| 10 | 2007 | 37 | |
| 11 | 1989 | 30 | |
| 12 | 2020 | 28 | |
| 13 | 2006 | 27 | |
| 14 | 1993 | 24 | |
| 15 | 2005 | 23 | |
| 16 | 2001 | 22 | |
| 17 | 2014 | 20 | |
| 18 | 2007 | 19 | |
| 19 | 2008 | 16 | |
| 20 | 2004 | 14 |
About Michael Cullen
Michael Cullen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Molecular Biology, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Testicular diseases and treatments (13 papers), Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (6 papers), Neutropenia and Cancer Infections (6 papers), Cancer therapeutics and mechanisms (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Oncology (964 citations), Clinical Biochemistry (186 citations), Pulmonary and Respiratory Medicine (487 citations), Pathology and Forensic Medicine (210 citations) and Emergency Medicine (95 citations). Michael Cullen has collaborated with scholars based in United Kingdom, United States and Czechia. Frequent co-authors include Michael A. Russell, Lucinda Billingham, Neil Steven, Claire Gaunt, Robert Huddart, Peter Simmonds, Simon Gollins, Mark Hastings, Andrew Stanley and Indrajit Fernando. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Journal of Thoracic Oncology, Cancer Chemotherapy and Pharmacology and Expert Review of Anticancer Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.